|
On Thursday, a Food and Drug Administration (FDA) advisory council recommended approval for an epilepsy drug that would be the first plant-derived cannabidiol medicine for prescription use in the US.
0 Comments
Roching Holdings (SWX: RO), a Swiss developer of pharmaceutical and therapeutic medicines used in oncology, has agreed to acquire Ignyta (NASDAQ: RXRX), a US developer of personalized-medicine therapies designed for autoimmune diseases.
Kindred Healthcare (NYSE: KND) will be acquired for $9.00 per share in cash by Humana (NYSE: HUM), TPG Capital, and Welsh, Carson, Anderson & Stowe (“WCAS”). The total consideration equates to approximately $4.1 billion.
UnitedHealth Group (NYSE: UNH) announced it will purchase the primary and urgent care unit of DaVita (NYSE: DVA) for $4.9 billion.
|
Archives
March 2019
Categories |
RSS Feed
|
|
|
Skyline Advisors is a division of Ideation Ventures, Inc. Services involving securities are offered through M&A Securities Group, Inc.4151 N Mulberry Drive Suite 252, Kansas City, MO, 64116 (“MAS") . Services involving real estate brokerage are offered through Berkshire Hathaway HomeServices Ambassador Real Estate ("BHHS"). Skyline, MAS, and BHHS are separate entities.
COPYRIGHT 2020. ALL RIGHTS RESERVED. |